SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-04-036594
Filing Date
2004-11-17
Accepted
2004-11-17 16:41:51
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a04-13270_110q.htm 10-Q 664760
2 EX-4.2 a04-13270_1ex4d2.htm EX-4.2 353727
3 EX-31.1 a04-13270_1ex31d1.htm EX-31.1 12008
4 EX-31.2 a04-13270_1ex31d2.htm EX-31.2 11317
5 EX-32.1 a04-13270_1ex32d1.htm EX-32.1 5034
6 EX-32.2 a04-13270_1ex32d2.htm EX-32.2 7114
  Complete submission text file 0001104659-04-036594.txt   1056135
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 041152578
SIC: 2834 Pharmaceutical Preparations